Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...

In this article, we are going to take a look at where Aligos Therapeutics, Inc. (NASDAQ:ALGS) stands against the other stocks. One of the strongest stock market anomalies is the momentum effect ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) saw a large increase in short interest in the month of December.As of December 31st, there was short interest totalling 597,300 shares ...

In this article, we are going to take a look at where Aligos Therapeutics, Inc. (NASDAQ:ALGS) stands against the other stocks. One of the strongest stock market anomalies is the momentum effect ...

Aligos Therapeutics (ALGS) has entered into a securities purchase agreement for a private placement that is expected to result in gross ...

SOUTH SAN FRANCISCO - Aligos Therapeutics, Inc. (NASDAQ:ALGS), a company specializing in therapies for liver and viral diseases with a current market capitalization of $96.58 million, announced today ...